The Use of a Triple-Emitter, UV-C Energy Disinfection System to Reduce CAUTI and CLABSI Rates


According to the CDC, roughly one in every 25 hospitalized patients has at least one healthcare-associated infection (HAI).1 HAIs create significant health risks and cost the healthcare industry billions of dollars each year. 

In 2014, Jersey Shore University Medical Center (JSUMC), which is a part of Hackensack Meridian Health, was experiencing an increase in Catheter-Associated Urinary Tract Infections (CAUTI) and Central Line-Associated Bloodstream Infections (CLABSI) in its Medical Intensive Care Unit (MICU).

In this Whitepaper, sponsored by Surfacide, find out what JSUMC introduced to the patient care environment that would impact the CAUTI and CLABSI rates.



Helios® by Surfacide is a revolutionary, patented triple emitter UV-C hard surface disinfection system. Designed to precisely target all areas even those hidden by shadows the Helios systems advanced laser mapping technology scans a room, creates a plan, and gets to work. Environments are safely disinfected and ready for use in just one efficient cycle.

Related Videos
Andrea Flinchum, 2024 president of the Certification Board of Infection Control and Epidemiology, Inc (CBIC) explains the AL-CIP Certification at APIC24
Antimicrobial Resistance (Adobe Stock unknown)
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Infection Control Today's topic of the month: Mental Health
Infection Control Today Topic of the Month: Mental Health
Mindful MD: 6 Ways Mindfulness Restores Your Autonomy and Cures Healthcare Burnout  (Photo credit: Tori Whitacre Martonicz)
Christopher Reid, PhD  (Photo courtesy of Christopher Reid, PhD)
3D illustration: Candida auris   (Adobe Stock 635576411 By Niamh )
Medical investigators going over data. (AdobeStock 589197902 by Wasan)
CDC logo is seen on a laptop. (Adobe Stock 428450603 by monticellllo)
Related Content